Related Experiment Videos
mRNA differential display: application in the discovery of novel pharmacological targets
X Wang1, R R Ruffolo, G Z Feuerstein
1Division of Pharmacological Sciences, SmithKline Beecham Pharmaceuticals, King of Prussia, PA 19406, USA.
Trends in Pharmacological Sciences
|August 1, 1996
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Synapse selection based on differences in synapse turnover.
International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience·2014
The use of differential display rt-PCR for identifying altered gene expression in ischemic brain injury.
Methods in molecular medicine·2011
Apoptosis and congestive heart failure.
Trends in cardiovascular medicine·2011
Effect of the small molecule plasminogen activator inhibitor-1 (PAI-1) inhibitor, PAI-749, in clinical models of fibrinolysis.
Journal of thrombosis and haemostasis : JTH·2010
P-selectin antagonism reduces thrombus formation in humans.
Journal of thrombosis and haemostasis : JTH·2009
Fifty years of Biochemical Pharmacology: the discipline and the journal.
Biochemical pharmacology·2008
Midnolin-directed protein degradation beyond ubiquitin.
Trends in pharmacological sciences·2026
Deubiquitinases in mitophagy: therapeutic control of mitochondrial quality.
Trends in pharmacological sciences·2026
AI virtual cells for drug discovery and pharmacology.
Trends in pharmacological sciences·2026
Pyroptotic pores reopen the case for caspase inhibitors.
Trends in pharmacological sciences·2026
Nitroxyl (HNO) therapeutics: exposure control and target engagement.
Trends in pharmacological sciences·2026
Emerging STAT1 post-translational modifications: mechanisms and translational perspectives.
Trends in pharmacological sciences·2026
In silico analysis of MALAT1 and H19 lncRNA interactions with the diabetes-related proteins ASK1 and YAP1.
In silico pharmacology·2026
DDA: a traceable multi-agent framework for automated structure-based drug design.
Frontiers in chemistry·2026